,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['enhertu', 'rectal']
was planning to cover #asco2022 in detail - but..... is it me or not much to talk about? seems as if enhertu and the rectal cancer story are the only meaningful updates......am i missing something?
Weekly Biotech Market Updates, Career Advice & Consulting | ?? Instagram: @bowtiedbiotech | ?? web: https://t.co/ayyMxLo0M9 | ??????